Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
What this study shows
mTOR controls mammalian cell size through its downstream translational targets S6K1 and 4E-BP1/eIF4E.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Mammalian cells) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Mammalian cells |
| Journal | Genes & development |
| Year | 2002 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1101/gad.995802 · PMID 12080086 · Free full text (PMC186342) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Genetic/pharmacologic (mTOR/S6K1/4EBP1) |
| Target | mTOR / S6K1 / 4EBP1-eIF4E |
| Model | Mammalian cells |
| Effect | Mammalian cell size is controlled by mTOR through its downstream targets S6K1 and 4EBP1/eIF4E |
In the Atlas
Related topics
Links in the pathway map
- Supports 4E-BP1 inhibits eIF4E
- Supports Rapamycin inhibits mTORC1
More studies on this topic
- Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling (2002)
- Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin (1997)
- Translational control of long-lasting synaptic plasticity and memory (2009)
- Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism (1999)
Was this page useful?
Thank you. Your answer was counted anonymously.